0.5296
전일 마감가:
$0.5386
열려 있는:
$0.546
하루 거래량:
614.47K
Relative Volume:
0.62
시가총액:
$52.29M
수익:
$322.20M
순이익/손실:
$-196.37M
주가수익비율:
-0.2851
EPS:
-1.8575
순현금흐름:
$27.02M
1주 성능:
-3.69%
1개월 성능:
-19.43%
6개월 성능:
-57.64%
1년 성능:
-76.47%
Docgo Inc Stock (DCGO) Company Profile
명칭
Docgo Inc
전화
(844) 443-6246
주소
685 THIRD AVENUE, NEW YORK
Compare DCGO vs HCA, THC, FMS, ENSG, UHS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DCGO
Docgo Inc
|
0.5296 | 53.19M | 322.20M | -196.37M | 27.02M | -1.8575 |
|
HCA
Hca Healthcare Inc
|
489.50 | 111.48B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
195.43 | 17.10B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.84 | 12.68B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
196.90 | 11.59B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
180.60 | 11.10B | 17.36B | 1.51B | 849.25M | 23.15 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-08-18 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-01-19 | 개시 | Stifel | Buy |
| 2021-12-21 | 개시 | Canaccord Genuity | Buy |
| 2021-12-07 | 개시 | Needham | Buy |
모두보기
Docgo Inc 주식(DCGO)의 최신 뉴스
DocGo (DCGO) price target decreased by 12.00% to 2.24 - MSN
DocGo | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
DocGo (DCGO) proxy: directors up for re-election; reverse split up to 1-for-10 - Stock Titan
Judge Approves $12.5M Deal To End Stock Drop Suit Against Health Care Company - Mealey's
Signal Recap: Is DocGo Inc a turnaround story2026 Stock Rankings & Long Hold Capital Preservation Tips - baoquankhu1.vn
DocGo Inc. (DCGO) Stock Price, News, Quote & History - Yahoo! Finance Canada
How DocGo (DCGO) Is Rewriting Its Story As Targets Fall And Transport Gains Focus - Yahoo Finance
DocGo stock surges on deal to acquire virtual care platform SteadyMD - MSN
DocGo Inc. (NASDAQ:DCGO) Given Average Rating of "Hold" by Brokerages - MarketBeat
DocGo Inc. (DCGO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
DocGo (DCGO) CEO Bienstock has 18,811 shares withheld to cover RSU taxes - Stock Titan
DocGo | 4: Statement of changes in beneficial ownership of securities-Officer Bienstock Lee - Moomoo
[SCHEDULE 13G/A] DocGo Inc. Amended Passive Investment Disclosure - Stock Titan
Canaccord cuts DocGo stock price target on profitability concerns By Investing.com - Investing.com Australia
DocGo (NASDAQ:DCGO) Given New $1.00 Price Target at Canaccord Genuity Group - MarketBeat
Canaccord cuts DocGo stock price target on profitability concerns - Investing.com
Analyst Calls: Can DocGo Inc ride the EV wave2026 Fundamental Recap & Weekly Return Optimization Alerts - baoquankhu1.vn
DocGo Inc. (NASDAQ:DCGO) Q4 2025 earnings call transcript - msn.com
Aug Action: What are DocGo Incs recent SEC filings showingPortfolio Profit Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT) - The Globe and Mail
Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies® - Eagle-Tribune
Healthcare provider DocGo joins 2026 World's Most Ethical Companies list - Stock Titan
DocGo Earnings Call Signals Turnaround Amid Cash Strain - TipRanks
DocGo Inc. (DCGO) reports Q4 loss, beats revenue estimates - MSN
Stifel cuts DocGo stock price target on transition year outlook By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates DocGo stock rating on 2026 outlook By Investing.com - in.investing.com
DocGo (NASDAQ:DCGO) Price Target Cut to $2.50 by Analysts at Stifel Nicolaus - MarketBeat
Cantor Fitzgerald reiterates DocGo stock rating on 2026 outlook - Investing.com
Stifel cuts DocGo stock price target on transition year outlook - Investing.com
DocGo (NASDAQ:DCGO) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
DocGo (NASDAQ:DCGO) Given "Buy" Rating at Needham & Company LLC - MarketBeat
DocGo Inc. (NASDAQ:DCGO) Q4 2025 Earnings Call Transcript - Insider Monkey
DocGo outlines 2026 revenue guidance of $290M–$310M as company targets profitability and explores strategic alternatives - MSN
DocGo Inc. 2025 Annual Report: Mobile Health Services, Business Strategy, Key Risks, and Corporate Overview - Minichart
DocGo Inc (DCGO) Q4 2025 Earnings Call Highlights: Revenue Surpasses Expectations Amid ... By GuruFocus - Investing.com Canada
DCGO SEC FilingsDOCGO INC 10-K, 10-Q, 8-K Forms - Stock Titan
DocGo (DCGO) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
DocGo Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: DocGo’s Q4 2025 results miss EPS but beat revenue - Investing.com South Africa
DocGo Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DocGo Inc. (DCGO) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
DocGo Q4 2025 Earnings Call: Financial Results & Forward-Looking StatementsNews and Statistics - IndexBox
DCGO: 2026 guidance raised on strong SteadyMD and transport growth, with profitability expected in H2 - TradingView
DocGo Q4 Earnings Call Highlights - MarketBeat
DocGo (DCGO) Q4 2025 Earnings Call Transcript - AOL.com
DocGo earnings missed by $1.23, revenue topped estimates - Investing.com Canada
DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
DocGo (NASDAQ:DCGO) Announces Quarterly Earnings Results - MarketBeat
DOCGO ($DCGO) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Docgo Inc (DCGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):